Human dental pulp as a source of native functional nociceptor pharmacology.
Billinton
Andy
A
Neurosciences Centre of Excellence for Drug Discovery, Pain and Neuroexcitability Discovery Performance Unit, GlaxoSmithKline, New Frontiers Science Park, 3rd Avenue, Harlow, Essex CM19 5AW, UK.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001681:Biological Assay / Q000379:methods*; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis / Q000378:metabolism; D003782:Dental Pulp / Q000294:innervation* / Q000378:metabolism; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D008964:Molar, Third / Q000294:innervation / Q000378:metabolism / Q000601:surgery; D009480:Neuropharmacology / Q000379:methods*; D009619:Nociceptors / Q000378:metabolism*; D017450:Receptors, Opioid, mu / Q000032:analysis / Q000378:metabolism; D011984:Sensory Receptor Cells / Q000378:metabolism*; D050916:TRPV Cation Channels / Q000032:analysis / Q000378:metabolism; D014098:Toothache / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology
D000700:Analgesics; D017450:Receptors, Opioid, mu; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human; D015740:Calcitonin Gene-Related Peptide